Cargando…
Intravitreal methotrexate for the treatment of proliferative vitreoretinopathy
BACKGROUND/AIMS: Preventing and treating proliferative vitreoretinopathy (PVR) remain a serious challenge for vitreoretinal surgeons. PVR is a devastating complication of retinal detachment that results in recurrent detachment and limits visual recovery. At present, there is no effective treatment f...
Autores principales: | Benner, Jeffrey David, Dao, David, Butler, John W, Hamill, Kelli I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528755/ https://www.ncbi.nlm.nih.gov/pubmed/31179399 http://dx.doi.org/10.1136/bmjophth-2019-000293 |
Ejemplares similares
-
Intravitreal methotrexate infusion for proliferative vitreoretinopathy
por: Sadaka, Ama, et al.
Publicado: (2016) -
Vitrectomy with Silicone Oil Tamponade and Single-Dose Intravitreal Methotrexate for Recurrent Retinal Detachment with Proliferative Vitreoretinopathy
por: Babel, Adrian, et al.
Publicado: (2022) -
Intravitreal methotrexate infusion for prophylaxis of proliferative vitreoretinopathy after pars plana vitrectomy for rhegmatogenous retinal detachment
por: Fouad Aziz, Joseph Hany, et al.
Publicado: (2022) -
Aerosolized, Gas-Phase, Intravitreal Methotrexate Reduces Proliferative Vitreoretinopathy in a Randomized Trial in a Porcine Model
por: Olsen, Timothy W., et al.
Publicado: (2023) -
Use of Intravitreal Methotrexate Infusion in Complicated Retinal Detachment for Prevention of Proliferative Vitreoretinopathy in a Pilot Study
por: Jahangir, Sana, et al.
Publicado: (2021)